Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa

Raugi, Dana N
Ba, Selly
Cisse, Ousseynou
Diallo, Khardiata
Tamba, Ibrahima Tito
Ndour, Cheikh
Badiane, Ndeye Mery Dia
Fortes, Louise
Diallo, Mouhamadou Baïla
Faye, Dominique
Smith, Robert A
Sall, Fatima
Toure, Macoumba
Sall, ElHadji Ibrahima
Diallo Agne, Habibatou
Faye, Khadim
Diatta, Jean Philippe
Sy, Marie Pierre
Chang, Ming
Diaw, Binetou
Sambou, Jacques
Bakhoum, Raphael
Sy, Mame Demba
Niang, Alassane
Malomar, Jean Jacques
Coombs, Robert W
Hawes, Stephen E
Ndoye, Ibra
Kiviat, Nancy B
Sow, Papa Salif
Seydi, Moussa
Gottlieb, Geoffrey S
Traore, Fatou
Cisse, Samba
Ndiaye, Ousseynou
Faye, Babacar
Simal, Fatou
Astou Diop, Ndeye
Bale Diop, Amadou
Fadam Diome, Marianne
Gomis, Juliette
Dieye, Therese
Benzekri, Noelle
Lin, John
Kenney, Donna
Starling, Alison
Critchlow, Cathy
Cherne, Steve
Song, Jennifer
Nixon, Robbie
Burhen, Pallas
Zavala, Chris
Wu, Vincent
Masoum, Sara
Leong, Sally
Montano, Alex
Oakes, Mariah
Olson, Julia
Blankenship, Lindsey
Pan, Charlotte
Parker, Kara
Parker, Kate
Hernandez, Alex
Church, Brad
Kim, Moon
Lu, Paul
Sorensen, Stefanie
Wong, Kim
Mullins, James

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA
Service des Maladies Infectieuses et Tropicales, Ibrahima Diop Mar, Centre Hospitalier National Universitaire de Fann, Universite Cheikh Anta Diop de Dakar, Dakar, Senegal
Centre de Sante de Ziguinchor, Ziguinchor, Senegal
Laboratory Medicine, Division of Virology, University of Washington, Seattle, Washington, USA
Epidemiology, University of Washington, Seattle, Washington, USA
Conseil National de Lutte Contre le SIDA du Senegal, Dakar, Senegal
Pathology, University of Washington, Seattle, Washington, USA
Global Health, University of Washington, Seattle, Washington, USA

Correspondence: D. N. Raugi, University of Washington School of Medicine, 750 Republican St, Bldg E, Rm 778, Seattle, WA 98109 ([email protected]).

Received December 03, 2019

Accepted March 12, 2020

Revised June 04, 2020

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Clinical Infectious Diseases 72(3):p 369-378, February 01, 2021. | DOI: 10.1093/cid/ciaa277

Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa

Corresponding Article

Human Immunodeficiency Virus Guidelines

Are We There Yet?

Corresponding Article

Human Immunodeficiency Virus–2 (HIV-2)

A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe